Global Epigenetics Market to 2025
www.theinsightpartners.com
EPIGENETICS MARKET To 2025 Global Analysis and Forecasts by Product (Reagents, Kits, Enzymes, Instruments & Consumables and Bioinformatics Tools), Technology (Histone Modification, DNA Methylation and Others), Application (Oncology, Cardiovascular Diseases and Others) End Users (Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organization) and Geography
1
Global Epigenetics Market to 2025
www.theinsightpartners.com
According to a new market research study titled ‘Epigenetics Market to 2025 - Global Analysis and Forecasts by Product, Technology, Application and End User. The global epigenetics market is expected to reach US$ 2,611.57 Mn in 2025 from US$ 991.45 in 2017. The market is estimated to grow with a CAGR of 13.6% from 2018-2025. The report highlights the trends prevalent in the global epigenetics market and the factors driving the market along with those that act as deterrents to its growth. Global epigenetics market, based on technology was segmented histone modification, DNA methylation and other technologies. In 2017, DNA methylation segment held the largest share of the market, by technology. The largest share of the DNA methylation is primarily owing to its ability to develop therapies for diseases including cancer, lupus, muscular dystrophy and various congenital defects and also it helps to prevent conditions that develop during embryonic development such as, abnormal methylation of the X-chromosome and gene imprinting. The market for epigenetics is expected to grow as declining prices of sequencing, increasing prevalence of cancer, funds & grants provided by government bodies are expected to fuel the market growth during the forecast period. In addition, promising precise treatments by neurogenetics are likely to have a positive impact on the growth of the market in the coming years. The major players operating in the epigenetics market are Merck KGaA, Thermo Fisher Scientific Inc., ABCAM Plc, Agilent Technologies, Active Motif, Qiagen, Bio-Rad Laboratories, Inc., Perkinelmer Inc., New England Biolabs (NEB), and Illumina Inc. For instance, in February, 2018, QIAGEN launches epigenetic breast cancer test in Europe. It is the first clinically validated DNA methylation assay that helps predict the response to anthracycline-based chemo by certain high-risk breast cancer patients. The report segments the global epigenetics market as follows: Global epigenetics Market - By Product
Reagents
Kits
Enzymes
Instruments & Consumables
Bioinformatics Tools
Global epigenetics Market - By Technology
Histone Modification
DNA Methylation
Others
2
Global Epigenetics Market to 2025
www.theinsightpartners.com
Global epigenetics Market - By Application
Metabolic Diseases
Oncology
Cardiovascular Diseases
Others
Global Epigenetics Market - By End User
Academics & Research Institutes
Contract Research Organizations
Biotechnology & Pharmaceutical Companies
Global Epigenetics Market - By Geography o
North America
o
U.S.
o
Canada
o
Mexico
o
Europe
o
U.K.
o
Germany
o
France
o
Asia Pacific (APAC)
o
Japan
o
China
o
India
o
Middle East & Africa (MEA)
o
South Africa
o
UAE
o
Saudi Arabia
o
South & Central America (SCAM)
o
Brazil
Check Sample Report
3
Global Epigenetics Market to 2025
www.theinsightpartners.com
ABOUT US The Insight Partners is a one-stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Technology, Media, and Telecommunication. Our research model is very simple. We believe in client servicing and delivering the best quality to our customers. Through our research content, we are making sure that our customers get value for their money along with better quality data and analysis. Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis, etc. We provide a detailed break-up of segmentation in terms of geography, technology, products, and services etc., which helps our clients to gain a deeper analytical understanding of various research topics.
CONTACT US If you have any queries about this report or would like further information, please contact us: North America:
+1 646 491 9876
Email:
sales@theinsightpartners.com
DISCLAIMER All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, “The Insight Partners”. The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that the findings, conclusions, and recommendations that “The Insight Partners” delivers will be based on information gathered in good faith from primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such, “The Insight Partners” can accept no liability whatsoever for actions taken based on any information that may subsequently prove to be incorrect.
4